Found: 3
Select item for more details and to access through your institution.
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study.
- Published in:
- European Neurology, 2014, v. 72, n. 3/4, p. 173, doi. 10.1159/000361044
- By:
- Publication type:
- Article
Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2014, v. 37, n. 4, p. 549, doi. 10.1007/s11239-013-0980-2
- By:
- Publication type:
- Article
Evidence for an abnormal cortical sensory processing in dystonia: selective enhancement of lower limb P37-N50 somatosensory evoked potential.
- Published in:
- 1999
- By:
- Publication type:
- journal article